PT1156791E - Bupropiona para tratar doencas virais - Google Patents

Bupropiona para tratar doencas virais

Info

Publication number
PT1156791E
PT1156791E PT99960723T PT99960723T PT1156791E PT 1156791 E PT1156791 E PT 1156791E PT 99960723 T PT99960723 T PT 99960723T PT 99960723 T PT99960723 T PT 99960723T PT 1156791 E PT1156791 E PT 1156791E
Authority
PT
Portugal
Prior art keywords
bupropiona
viral diseases
treat viral
virus
hsv2
Prior art date
Application number
PT99960723T
Other languages
English (en)
Inventor
Christopher William Reindler
Original Assignee
Planisphere Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Planisphere Corp filed Critical Planisphere Corp
Publication of PT1156791E publication Critical patent/PT1156791E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
PT99960723T 1998-12-08 1999-12-07 Bupropiona para tratar doencas virais PT1156791E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13549498P 1998-12-08 1998-12-08

Publications (1)

Publication Number Publication Date
PT1156791E true PT1156791E (pt) 2005-08-31

Family

ID=22468359

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99960723T PT1156791E (pt) 1998-12-08 1999-12-07 Bupropiona para tratar doencas virais

Country Status (14)

Country Link
US (2) US6512011B1 (pt)
EP (1) EP1156791B1 (pt)
JP (1) JP4166955B2 (pt)
AT (1) ATE295159T1 (pt)
AU (1) AU762624B2 (pt)
BR (1) BR9916963A (pt)
CA (1) CA2349487C (pt)
DE (1) DE69925312T2 (pt)
ES (1) ES2242438T3 (pt)
HK (1) HK1042239B (pt)
MX (1) MXPA01005725A (pt)
NZ (1) NZ512716A (pt)
PT (1) PT1156791E (pt)
WO (1) WO2000033827A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030134905A1 (en) * 2002-01-11 2003-07-17 Reindler Christopher William Bupropion to treat viral diseases
DE102004063132A1 (de) * 2004-12-22 2006-07-06 Schmiegel, Wolff, Prof. Dr. Verwendung von Bupropion in Arzneimittel zur Behandlung von Hepatitis C
EP2502621A1 (en) * 2005-06-27 2012-09-26 Valeant International (Barbados) SRL Crystalline forms of bupropion HBr
JP2013501770A (ja) * 2009-08-10 2013-01-17 バイオコピア リミテッド ウイルス感染症の治療
GB2477584A (en) * 2010-02-04 2011-08-10 Biocopea Ltd A compound for use in treating an acute viral infection
CN108721262A (zh) * 2017-04-13 2018-11-02 中国科学院武汉病毒研究所 安非他酮在制备治疗或预防流感病毒感染的药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438138A (en) * 1982-12-06 1984-03-20 Burroughs Wellcome Co. Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone
US4507323A (en) * 1984-07-25 1985-03-26 Burroughs Wellcome Co. Treatment of psychosexual dysfunctions
US5753712A (en) * 1994-02-18 1998-05-19 Pinsker; Walter Treatment of migraine headaches and formulations
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer

Also Published As

Publication number Publication date
US6512011B1 (en) 2003-01-28
HK1042239B (zh) 2005-12-09
ES2242438T3 (es) 2005-11-01
MXPA01005725A (es) 2003-07-14
CA2349487C (en) 2007-09-11
WO2000033827A1 (en) 2000-06-15
JP2002531495A (ja) 2002-09-24
EP1156791A4 (en) 2002-05-02
HK1042239A1 (en) 2002-08-09
AU1762900A (en) 2000-06-26
EP1156791B1 (en) 2005-05-11
BR9916963A (pt) 2002-03-05
US20020173551A1 (en) 2002-11-21
CA2349487A1 (en) 2000-06-15
JP4166955B2 (ja) 2008-10-15
DE69925312T2 (de) 2006-03-09
DE69925312D1 (de) 2005-06-16
NZ512716A (en) 2003-10-31
EP1156791A1 (en) 2001-11-28
AU762624B2 (en) 2003-07-03
ATE295159T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
BRPI0518861A2 (pt) compostos, sais ou hidratos farmaceuticamente aceitos, composição farmacêutica e métodos de modulação de atividades imuno das citocinas e de tratamento da infecção por vìrus da hepatite c em paciente
IL157504A0 (en) Oncolytic virus therapy
MY117892A (en) Therapeutic compounds
DE69030880T2 (de) Zusammensetzung zur Stimulierung des Immunsystems
WO2003051306A3 (en) N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
PT668763E (pt) Utilizacao de fenserina para a preparacao de medicamentos para tratar doencas do conhecimento
IL161889A0 (en) Method for treating diseases with omega interferon
DE60030732D1 (de) Verwendung von 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol zur prävention oder behandlung viraler myocarditis
PT1156791E (pt) Bupropiona para tratar doencas virais
CA2504872A1 (en) Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
ZA991749B (en) Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy.
MX9805441A (es) Compuestos terapeuticos.
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
WO2000016786A3 (en) Oxihumic acid and its use in the treatment of various conditions
DE3872881T2 (de) Arzneimittelzusammensetzung zur vorbeugung und behandlung bakterieller und viraler krankheiten.
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
PL367204A1 (en) Use of l-carnitine as stabilizing agent of proteins
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
DE69428797D1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
EP0642793A4 (en) Apoptosis inducer.
RU2000108989A (ru) Способ профилактики и лечения респираторных болезней телят
TH17663B (th) การใช้สารออกฤทธิ์แบร์ดีย์ไคนีนสำหรับเตรียมตัวยาหลักเพื่อรักษาโรคติดเชื้อไวรัส
SU1565027A1 (ru) Инактиватор вируса западного нила